Medical device performance is inextricably linked to the characteristics of the plastics used. Enhanced properties such as strength, flexibility, transparency, biocompatibility, and temperature and chemical resistance ensure patient safety. They are also mandated by the stringent regulations and classifications of the Food and Drug Administration (FDA) and The U.S. Pharmacopeial Convention (USP).
Recently, Kaysun earned MedAccred Plastics accreditation. Our commitment to excellence is well documented through other certifications including ISO 13485:2016 and IATF 16949:2016. However, the MedAccred designation puts Kaysun in an elite group of injection molders that can capably and confidently serve the medical industry — assuring medical OEMs of an unparalleled benchmark of production and quality standards.
With careful planning, complex injection molding can reduce costs, optimize functionality and improve aesthetics in medical devices.
The Kaysun Blog is a valuable year-round resource for advice and information about complex injection molding. We have our subscribers to thank for its continued popularity, and look forward to providing you with even more helpful insights throughout 2019.
For now, let’s take a look back at the four most popular blog posts of 2018:
Thousands of medical industry professionals, thought leaders and suppliers met in Minnesota October 31-November 1 at Medical Design & Manufacturing (MD&M) Minneapolis 2018 — the midwest’s largest medical technology trade show.
As both an exhibitor and guest at MD&M, the Kaysun team learned a lot about what’s currently happening and evolving in the medical industry. Here are three of the most talked-about trends:
Medical Design & Manufacturing (MD&M) Minneapolis — the midwest’s largest medical technology trade show — is slated for October 31-November 1, 2018 at the Minneapolis Convention Center, and it’s a can’t miss event for anyone involved in the design, manufacture or distribution of medical devices and components.
Not surprisingly, the medical industry in the United States is one of the most heavily regulated. The U.S. Food & Drug Administration (FDA) has a strict protocol around medical device tracking, particularly Class II and Class III devices that are intended for life support away from a primary care facility or whose failure would likely cause serious adverse health consequences.
Injection molding partner selection is a high priority in most industries, but finding the right fit takes on particular significance when that relationship is relied upon for making critical-use products within the heavily regulated medical field.
Constantly evolving, the medical industry requires OEMs to be forward-thinking in providing solutions that address trends and challenges. One such OEM, Smiths Medical, sought to change the design of its existing pulse oximetry portfolio to include enhanced functionality and improved manufacturability. At the project’s inception, they partnered with the U.S.-based injection molding experts at Kaysun to help refine and ultimately accomplish their goals.